The XCELL BMC System
Designed With You In Mind
XCELL BMC
We spoke to hundreds of physicians about what they would like to see in a BMC system. Using this information, we worked with PhDs and engineers to develop XCELL BMC.
XCELL BMC is revolutionary in its ability to maximize MSC count in such an affordable and easy-to-use system. This system has a specialized device that helps shorten total processing time and reduces human error in the processing steps to maximize total nucleated cell concentration numbers.
Sound Available
XCELL BMC System Collection
Available Sizes and Product Number
30mL XCELL BMC Processing Quick Start Guide
60mL/120mL XCELL BMC Processing Quick Start Guide
30mL : XC-BMC-30 | Instructions for Use
60mL : XC-BMC-60 | Instructions for Use
120mL: XC-BMC-120 | Supplemental Instructions for Use
Kit Includes
Contents: | 30mL Kit | 60mL Kit | Supplemental Kit for 120mL Procedures |
|---|---|---|---|
APEX P30A Concentrating Device | 1 | 0 | 0 |
APEX P60A Concentrating Device | 0 | 1 | 1 |
Apex P60A Cap | 0 | 1 | 1 |
Syringe 30mL (Luer Lock) | 2 | 0 | 0 |
Syringe 60mL (Luer Lock) | 0 | 2 | 0 |
Syringe 10mL (Luer Lock) | 5 | 9 | 9 |
18g X 1.5" Needle | 1 | 1 | 0 |
150um In-Line Filter | 1 | 1 | 0 |
45 Degree Dispensing Tip | 0 | 1 | 1 |
Straight Dispensing Tip | 1 | 0 | 0 |
Gauze Sponge 4 x 4 / 8 Ply | 5 | 5 | 0 |
Utility Drape | 1 | 1 | 0 |
Gassine Bag | 2 | 2 | 1 |
Alcohol Prep Pad | 4 | 4 | 0 |
Universal Male / Female Cap | 2 | 2 | 1 |
Female Vented Cap (Luer Lock) | 4 | 8 | 8 |
Male Vented Cap (Luer Lock) | 4 | 4 | 0 |
Female to Female Connector | 1 | 1 | 0 |
Adhesive Patient Labels | 5 | 5 | 0 |
Low-Profile Cap (Luer Lock) | 0 | 1 | 1 |
Prep Towel | 0 | 0 | 1 |
High Concentration Levels
The kit is designed to recover a high percentage of total nucleated cells and progenitors from centrifuged bone marrow aspirate in a one-step process with minimal sterile breaks.
Designed With You in Mind
We spoke to hundreds of physicians about what they would like to see in a BMC system. Using this information, we worked with PhDs and engineers to develop XCELL BMC.
Preliminary results indicate a recovery of greater than 80% of all nucleated white cells, representing more than 5X over baseline BMA levels, with the flexibility to deliver 3-12cc of BMC, based on the user’s requirements.
